Journal article
The Second Canadian Gastroesophageal Reflux Disease Consensus: Moving Forward to New Concepts
Abstract
Gastroesophageal reflux disease (GERD) is a disease with serious consequences that may result in significant impairment in quality of life and disease morbidity. Across all grades of severity of symptoms and severity of underlying esophageal disease, proton pump inhibitors (PPIs) provide therapeutic gains over prokinetics (PKs) or H2 receptor antagonists (H2RAs). The potential cost effectiveness of using medications with higher acquisition …
Authors
Thomson A; Chiba N; Armstrong D; Tougas G; Hunt R
Journal
Canadian Journal of Gastroenterology and Hepatology, Vol. 12, No. 8, pp. 551–556
Publisher
Hindawi
Publication Date
1998
DOI
10.1155/1998/925346
ISSN
2291-2789